Dr. Daniel Prince is president of Gibraltar Laboratories Inc. He has led the Company’s expansion and growth since 1987. Gibraltar Laboratories Inc. was founded in 1970 by Dr. Herbert Prince, co-discoverer of a cure for Hodgkin's disease (Procarbazine) and also involved with the team that developed the drug BACTRIM (TMP-Sulfa) now used extensively in the treatment of MRSA infections, Gibraltar Laboratories, Inc. (GBL) has over 37 years of exemplary service to its credit.